Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4/mitogen‐activated protein kinase and TLR4/nuclear factor‐κB pathways and autophagy-Reference-Cited by-同舟云学术

Tectorigenin protects against experimental fulminant hepatic failure by regulating the TLR4/mitogen‐activated protein kinase and TLR4/nuclear factor‐κB pathways and autophagy

Published:2019-01-30 Issue:4 Volume:33 Page:1055-1064
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Zhang Lingjian¹^ORCID,Zhao Yalei¹,Fan Linxiao¹,Xu Kai²,Ji Feiyang¹,Xie Zhongyang¹,Ouyang Xiaoxi¹,Wu Daxian¹,Li Lanjuan¹^ORCID

Affiliation:

1. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated HospitalZhejiang University School of Medicine Hangzhou China

2. Department of Orthopaedic Surgery, Second Affiliated HospitalZhejiang University School of Medicine Hangzhou China

Funder

National Basic Research Program of China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.6299

Reference31 articles.

1. Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation

2. The importance of immune dysfunction in determining outcome in acute liver failure